Home
About Us
Corporate Profile
Milestones
Investment Partners
Corporate News
Products
Technological Innovation
Product Description
Guideline & Consensus
Sustainalibity
Corporate Values
Investor Relations
Discipline Development
Join Us
Contact Us
Language
简体中文
English
sustainable development
Corporate values
RuiNing RuiXun | RuiNing Bio’s “Embolization Hydrogel” has been awarded the “2026 Outstanding Product Innovation Award” at the 15th CFS Financial Summit.
View Details
2026-08-03
The second session of the “Injectable Absorbable Isolation Hydrogel Training Course” at the Tumor Center of Tongji Hospital, Huazhong University of Science and Technology, has concluded successfully.
2026-07-29
New progress in deepening Shanghai–Xinjiang medical cooperation: Xinjiang’s first case of precision radiotherapy for prostate cancer assisted by Respacio® has been successfully performed.
2026-07-13
The “Absorbable Isolation Hydrogel Injection Training Course” concluded successfully at the Oncology Center of Tongji Hospital, affiliated with Huazhong University of Science and Technology.
2026-06-29
The inauguration ceremony of the Fudan–RuiNing Bio–ZuQuan “Future Intelligent Hydrogel Industry–University Joint Laboratory” was held successfully.
2026-06-16
Respacio® isolation gel from Ruining Bio has been deployed for its first clinical use in cervical cancer patients at Wuhan Union Hospital.
2026-06-11